Literature DB >> 19727845

Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line.

Katrin Scheinemann1, Marie-Chantal Ethier, L Lee Dupuis, Susan E Richardson, John Doyle, Upton Allen, Lillian Sung.   

Abstract

PURPOSE: The utility of peripheral blood cultures in febrile neutropenic children with cancer and central venous catheters (CVC) is controversial. Our primary objective was to describe true bloodstream infections detected only by peripheral culture. Our secondary objectives were to describe true bloodstream infections detected only by CVC culture and to describe probable contaminants detected in both types of blood cultures.
METHODS: We included children with cancer who had peripheral and CVC cultures obtained on the same day in which at least one culture was positive. Only cultures obtained prior to the initiation of broad-spectrum antibiotics were included. We defined true bloodstream infections due to common contaminants (such as coagulase-negative Staphylococcus) as occurring if multiple cultures were positive for the same organism or if sepsis was present.
RESULTS: Between January 2002 and July 2007, 318 episodes of bloodstream infection from 224 children were included. Of these, 228/318 (71.7%) were classified as true bloodstream infections while 90/318 (28.3%) were classified as contaminants. Importantly, 28/228 (12.3%) true bloodstream infections were detected only in peripheral culture while 85/228 (37.3%) true bloodstream infections were detected only by CVC cultures. Contaminants were identified in peripheral culture in 45/318 (14.2%) of episodes and in CVC culture in 45/318 (14.2%) episodes.
CONCLUSIONS: True bloodstream infections frequently are only detected in the peripheral culture. These data support continuation of the practice of routine peripheral cultures in addition to CVC cultures at the onset of fever for children with cancer who are not already receiving broad-spectrum antibiotics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19727845     DOI: 10.1007/s00520-009-0725-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  13 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Frequency of low-level bacteremia in children from birth to fifteen years of age.

Authors:  J A Kellogg; J P Manzella; D A Bankert
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 3.  Comparison of utility of blood cultures from intravascular catheters and peripheral veins: a systematic review and decision analysis.

Authors:  Matthew E Falagas; Maria S Kazantzi; Ioannis A Bliziotis
Journal:  J Med Microbiol       Date:  2008-01       Impact factor: 2.472

4.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

5.  Clinical utility of blood cultures drawn from central vein catheters and peripheral venipuncture in critically ill medical patients.

Authors:  Michelle Beutz; Glenda Sherman; Jennie Mayfield; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2003-03       Impact factor: 9.410

6.  Reliability of blood cultures collected from intravascular catheter versus venipuncture.

Authors:  J K Bryant; C L Strand
Journal:  Am J Clin Pathol       Date:  1987-07       Impact factor: 2.493

7.  Comparison of contamination rates of catheter-drawn and peripheral blood cultures.

Authors:  E S McBryde; M Tilse; J McCormack
Journal:  J Hosp Infect       Date:  2005-06       Impact factor: 3.926

Review 8.  International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.

Authors:  Brahm Goldstein; Brett Giroir; Adrienne Randolph
Journal:  Pediatr Crit Care Med       Date:  2005-01       Impact factor: 3.624

9.  Diagnosis of catheter-related bloodstream infections among pediatric oncology patients lacking a peripheral culture, using differential time to detection.

Authors:  Aditya H Gaur; Patricia M Flynn; Daniel J Heine; Mary Anne Giannini; Jerry L Shenep; Randall T Hayden
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

10.  Yield of positive blood cultures in pediatric oncology patients by a new method of blood culture collection.

Authors:  A G Kaditis; A S O'Marcaigh; K H Rhodes; A L Weaver; N K Henry
Journal:  Pediatr Infect Dis J       Date:  1996-07       Impact factor: 2.129

View more
  9 in total

1.  Increased blood culture sensitivity in pediatric oncology patients: is it the peripheral culture or increased collected blood volume?

Authors:  Thomas V Adamkiewicz
Journal:  Support Care Cancer       Date:  2010-05-16       Impact factor: 3.603

2.  Repeat blood cultures in children with persistent fever and neutropenia: Diagnostic and clinical implications.

Authors:  Rachel L Wattier; Christopher C Dvorak; Andrew D Auerbach; Peggy S Weintrub
Journal:  Pediatr Blood Cancer       Date:  2015-03-01       Impact factor: 3.167

3.  Discrepant results from sampling different lumens of multilumen catheters: the case for sampling all lumens.

Authors:  J Cuellar-Rodriguez; D Connor; P Murray; J Gea-Banacloche
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-03       Impact factor: 3.267

Review 4.  Utility of peripheral blood cultures in patients with cancer and suspected blood stream infections: a systematic review.

Authors:  Laura Rodríguez; Marie-Chantal Ethier; Bob Phillips; Thomas Lehrnbecher; John Doyle; Lillian Sung
Journal:  Support Care Cancer       Date:  2012-04-29       Impact factor: 3.603

5.  Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia.

Authors:  Nagua Giurici; Giulio A Zanazzo
Journal:  Pediatr Rep       Date:  2011-02-24

Review 6.  Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Authors:  Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann
Journal:  GMS Hyg Infect Control       Date:  2016-05-12

7.  Impact of a modified Broviac maintenance care bundle on bloodstream infections in paediatric cancer patients.

Authors:  Rhoikos Furtwängler; Carolin Laux; Norbert Graf; Arne Simon
Journal:  GMS Hyg Infect Control       Date:  2015-11-16

8.  Could CD64 expression be used as a predictor of positive culture results in children with febrile neutropenia?

Authors:  Gustavo Göhringer de Almeida Barbosa; Mariela Granero Farias; Helena Cocolichio Ludwig; Isabel Stensmann; Matheus Vanzin Fernandes; Mariana Bohns Michalowski; Liane Esteves Daudt
Journal:  Rev Bras Hematol Hemoter       Date:  2015-10-09

9.  Guidance Statement for the Management of Febrile Neutropenia in Pediatric Patients Receiving Cancer-Directed Therapy in Central America and the Caribbean.

Authors:  Mario Melgar; Tea Reljic; Guillermo Barahona; Kattia Camacho; Alicia Chang; Johanny Contreras; Darrell Espinoza; Dora Estripeaut; Mario Gamero; Marco Luque; Girlande Mentor; Pamela Zacasa; Maysam Homsi; Miguela A Caniza; Ambuj Kumar; Sheena Mukkada
Journal:  JCO Glob Oncol       Date:  2020-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.